Health

CenTrak Appoints Steffi Thorlichen as Chief Customer Experience Officer to Enhance Healthcare Client Outcomes

NEWTOWN, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) -- CenTrak, the leader in Real-Time Location System (RTLS) solutions, proudly announces the…

1 week ago

Vaso Corporation Announces Financial Results for Third Quarter 2024

November 14, 2024 09:00 ET | Source: Vaso Corporation PLAINVIEW, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”)…

1 week ago

Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit

Presentation to highlight advances in fibrostenotic Crohn’s Disease and the potential of localized PDE4 inhibition Carlsbad, CA, Nov. 14, 2024 (GLOBE…

1 week ago

ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones

ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year.Incremental Payments Received…

1 week ago

SoldierStrong to Support Veterans with Novel Immersive Healthcare Technology

November 14, 2024 09:00 ET | Source: SoldierStrong SoldierStrong to support the physical rehabilitation of the men and women of…

1 week ago

Sparian Biosciences Announces Formation of its Science Advisory Board

​NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Sparian Biosciences, Inc. (“Sparian”), a clinical-stage CNS-focused biopharmaceutical company, is proud to…

1 week ago

Zyls Powered by Z-pod technology named twice as a finalist in the prestigious C&T All Awards

GREENVILLE, SC, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Zylö’s patented Z-pod® topical delivery platform was recently named as a 2025…

1 week ago

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

November 13, 2024 12:22 ET | Source: Cyclacel BERKELEY HEIGHTS, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc.…

1 week ago

Zealand Pharma to participate in the Jefferies London Healthcare Conference

Press Release – No. 11 / 2024 Zealand Pharma to participate in the Jefferies London Healthcare Conference Copenhagen, Denmark, November 13,…

1 week ago

PHAXIAM Reports Third-Quarter 2024 Financial Information

Cash and cash equivalents of €5.7 million as of September 30, 2024Execution of clinical strategy as planned, with the GLORIA…

1 week ago